Emerging Alternative Pain Relief Brand NeoRelief Reaffirms Commitment to Gentle, Non-Addictive OTC Choices

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180430005260/en/

Emerging OTC pain relief brand NeoRelief provides plant-powered, non-addictive opioid alternatives, easing healthcare system costs by billions. (Graphic: Business Wire)

Expanding self-care pain relief

“I was tired of seeing my father suffer from arthritis-related pain that held him back from a more joyful life,” said Dan Kaline, NeoRelief formulator. “As I searched for pain relief solutions with him, I soon realized there was a gap in the marketplace. At that point, I redirected my clinical career from patient care toward homeopathic formulation.”

NeoRelief therapeutic gels and creams work with the body’s natural capabilities for healing through the use of active botanicals and minerals known for their anti-inflammatory and healing properties. Gentle on sensitive skin, all NeoRelief formulas are free of counterirritants, dyes, and perfumes. The product line includes four alternative pain relief formulas for children and adults experiencing temporary to prolonged pain associated with the back, shoulders, joints, muscles, legs, menstrual cycle, and wounds. A complete list of products and their ingredients are available online at neorelief.com. Products retail as individual bottles and by the case, beginning at 16 dollars.

“As a young, emerging business with roots going back six years, we’re committed to alleviating the barriers pain can place within the lives of people of all ages and activity levels — from the young and avid athletes to those struggling with prolonged pain,” said Kevin DeVisser, CEO of BioLyte Laboratories, a Michigan-based pharmaceutical manufacturer and parent brand to NeoRelief. “We’ve recently rebranded the NeoRelief products as a way to further demonstrate that commitment and figuratively wave to customers from the crowded OTC shelves with our vibrant wave design.”

Pain management at a national level

A record number of 42,000 deaths from opioid overdose in 2016, as cited by the Center for Disease Control, underscore the need for a national emphasis on pain management. Although opioid prescription rates have declined to 66.5 prescriptions per 100 persons, their lowest rate since 2006, there’s still a great deal of health outreach needed.

The U.S. Department of Health and Human Services is expanding outreach to improve these five areas of pain management:

• Better addiction prevention, treatment and recovery services
• Better targeting of overdose reversing drugs
• Better data
• Better pain management
• Better research

“Taking national pain outreach one step further, people should be empowered to better understand their pain relief options and the ingredients they’re putting in and on their bodies,” added DeVisser. “Ongoing generations of allergies, heightened pain levels, and fluctuating energy levels confirm there’s still so much we all can do to work with our bodies instead of against them.”

OTC trends

According to the U.S. Department of Commerce, OTC drugs are considered by regulators to be safe for self-diagnosis and self-medication. Homeopathic products like NeoRelief are listed with but not regulated by the Food and Drug Administration. Nationally, there are about 100,000 OTC drug products marketed and sold and that number is expected to climb due to an aging population, consumer trends toward self-medication, and increased conversions of prescription drugs to OTC status. NeoRelief products are available online and through retailers such as pharmacies, medical offices, spas, and fitness centers.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180430005260/en/